# Efficacy and Safety Study of a 4-Month Post-Renal Transplant Dose Reduction of Tacrolimus(ADEQUATE)

> **NCT01744470** · PHASE4 · UNKNOWN · sponsor: **University Hospital, Tours** · enrollment: 286 (actual)

## Conditions studied

- De Novo Transplant Disease

## Interventions

- **DRUG:** Tacrolimus targeted half-dose
- **DRUG:** Tacrolimus targeted plain dose

## Key facts

- **NCT ID:** NCT01744470
- **Lead sponsor:** University Hospital, Tours
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-05
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 286 (ACTUAL)
- **Last updated:** 2014-04-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01744470

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01744470, "Efficacy and Safety Study of a 4-Month Post-Renal Transplant Dose Reduction of Tacrolimus(ADEQUATE)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01744470. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*